Moderna, Inc. (NASDAQ:MRNA) today announced that it has been awarded a tender for the supply of its mRNA COVID-19 vaccine in the European Union (EU), Norway and North Macedonia. Under the resulting ...
Moderna awarded tender for the supply of Its mRNA Covid-19 vaccine in European Union: Cambridge, Massachusetts Monday, January 27, 2025, 12:00 Hrs [IST] Moderna, Inc. announced th ...
Surveys take pulse on growing number of Americans who support option to opt children out of vaccines
Researchers say the number of Americans who support letting parents choose whether to vaccinate their children has grown ...
Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, Norway, and North Macedonia. Read more here.
The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS ...
Under the agreement, 17 participating countries could order an updated version of the biotech company's mRNA Covid-19 vaccine for up to four years. The vaccine, marketed as Spikevax in Europe, was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback